A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer

BACKGROUND: Tumor-derived autophagosome vaccines (DRibbles) have the potential to broaden immune response to poorly immunogenic tumors. METHODS: Autologous vaccine generated from tumor cells harvested from pleural effusions was administered to patients with advanced NSCLC with the objectives of asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanborn, Rachel E., Ross, Helen J., Aung, Sandra, Acheson, Anupama, Moudgil, Tarsem, Puri, Sachin, Hilton, Traci, Fisher, Brenda, Coffey, Todd, Paustian, Christopher, Neuberger, Michael, Walker, Edwin, Hu, Hong-Ming, Urba, Walter J., Fox, Bernard A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735525/
https://www.ncbi.nlm.nih.gov/pubmed/29258618
http://dx.doi.org/10.1186/s40425-017-0306-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735525/
https://www.ncbi.nlm.nih.gov/pubmed/29258618
http://dx.doi.org/10.1186/s40425-017-0306-6

Ejemplares similares